News from Tuesday, January 6, 2026
Articles
Make Drug Prices Great Again Without Price Controls
(1/6, Charles Sauer, RealClear Markets) comments “...Most favored nation pricing deprives American consumers of several advantages they currently enjoy, like having access to new medicines before they are made available to the rest of the world. Darius Lakdawalla and Dana Goldman of the University of Southern California’s Schaefer Institute for Public Policy and Government Service write, ‘as the world's largest market for pharmaceuticals, America finds itself in the unique position of accruing the lion's share of the benefits from new medicines. We often recoup these additional costs in the form of longer and healthier lives.’ These benefits are put at risk by price control schemes.” Full
Press Releases
UBC Acquires Evidinno Outcomes Research, Expanding Real-World Evidence and HEOR Capabilities
(1/6, United BioSource Press Release) “...‘Joining UBC marks an important step in expanding the reach and influence of Evidinno’s scientific and methodological expertise,’ said Dr. Mir Sohail Fazeli, MD, PhD, Chief Executive Officer of Evidinno. ‘By combining our HTA- and regulatory-grade evidence synthesis solutions, real-world research, and economic modeling capabilities with UBC’s global platform, we are well positioned to deliver robust, decision-ready evidence that supports sponsors and improves outcomes for patients world-wide.’” Full
Journals
A Retrospective Comparative Analysis of Transforaminal Epidural Steroid Injections and Percutaneous Transforaminal Endoscopic Discectomy for Managing Lumbar Radiculopathy in Super Elderly Patients
Jian Zhou, et al.
December 31, 2025, Clinical Interventions in Aging
Comparative Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors Versus Glucagon-Like Peptide-1 (GLP-1) Agonists on Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
Aymen A. Alqurain, et al.
January 6, 2026, Cureus
Population-Adjusted Network Meta-Analyses Provide New Insights into the Efficacy of Treatment Alternatives for Metastatic Castration-Sensitive Prostate Cancer
Neal Shore, et al.
January 6, 2026, Journal of Comparative Effectiveness Research